Literature DB >> 10618079

Differentiation among members of the Mycobacterium tuberculosis complex by molecular and biochemical features: evidence for two pyrazinamide-susceptible subtypes of M. bovis.

S Niemann1, E Richter, S Rüsch-Gerdes.   

Abstract

The variations in biochemical as well as molecular characteristics among several members of the Mycobacterium tuberculosis complex that are not M. tuberculosis have been assessed to facilitate an unambiguous species identification. Altogether, 96 M. tuberculosis complex strains including 52 M. bovis isolates and 44 M. africanum isolates were analyzed by spoligotyping. The strains could be clustered into five spoligotype groups. All M. bovis isolates showed the typical absence of the spacers 39 to 43 and typical biochemical properties. However, within these strains we found a group of strains that had a spoligotype pattern which is clearly defined by the additional absence of spacers 3 to 16 and that were uncommonly susceptible to pyrazinamide (PZA). This spoligotype pattern has previously been described as being typical for a caprine genotype because of its predominant isolation from sheep and goats. Due to the clinical importance of PZA resistance, we propose two M. bovis subtypes: M. bovis subtype bovis, which is resistant to PZA, and M. bovis subtype caprae, which is susceptible to PZA. Two additional strains that clustered in group 3 showed biochemical and genetic properties typical for M. bovis and were also sensitive to PZA; thus, they may represent a third PZA-susceptible M. bovis subtype. The M. africanum isolates could be clustered into two spoligotype groups which can be differentiated from M. bovis by hybridization to spacers 39 to 43. These groups correspond to the previously described M. africanum subtypes I and II and can be clearly distinguished from each other by spoligotyping and resistance to thiophen-2-carboxylic acid hydrazide. Our results demonstrate that spoligotyping is a useful tool for differentiation of M. bovis and M. africanum. Moreover, we describe two PZA-susceptible M. bovis subtypes and describe a method that facilitates an unambiguous differentiation of the two M. africanum subtypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618079      PMCID: PMC86043          DOI: 10.1128/JCM.38.1.152-157.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Genotypic identification of mycobacteria by nucleic acid sequence determination: report of a 2-year experience in a clinical laboratory.

Authors:  P Kirschner; B Springer; U Vogel; A Meier; A Wrede; M Kiekenbeck; F C Bange; E C Böttger
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

2.  Genomic analysis of Mycobacterium bovis and other members of the Mycobacterium tuberculosis complex by isoenzyme analysis and pulsed-field gel electrophoresis.

Authors:  M M Feizabadi; I D Robertson; D V Cousins; D J Hampson
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  [The so-called African mycobacteria strains from the tropical West Africa].

Authors:  G Meissner; K Schröder
Journal:  Zentralbl Bakteriol Orig       Date:  1969

4.  Identification of Mycobacterium kansasii by using a DNA probe (AccuProbe) and molecular techniques.

Authors:  E Richter; S Niemann; S Rüsch-Gerdes; S Hoffner
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

5.  Assessment of genetic markers for species differentiation within the Mycobacterium tuberculosis complex.

Authors:  E Liébana; A Aranaz; B Francis; D Cousins
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

6.  Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.

Authors:  A Scorpio; Y Zhang
Journal:  Nat Med       Date:  1996-06       Impact factor: 53.440

7.  Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis.

Authors:  P Del Portillo; L A Murillo; M E Patarroyo
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

Review 8.  Mycobacterial taxonomy.

Authors:  T M Shinnick; R C Good
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

9.  Extensive DNA sequence conservation throughout the Mycobacterium tuberculosis complex.

Authors:  R Frothingham; H G Hills; K H Wilson
Journal:  J Clin Microbiol       Date:  1994-07       Impact factor: 5.948

10.  Fourth report of the cooperative, open-ended study of slowly growing mycobacteria by the International Working Group on Mycobacterial Taxonomy.

Authors:  L G Wayne; R C Good; M I Krichevsky; Z Blacklock; H L David; D Dawson; W Gross; J Hawkins; V V Levy-Frebault; C McManus
Journal:  Int J Syst Bacteriol       Date:  1991-10
View more
  44 in total

1.  Is Mycobacterium africanum subtype II (Uganda I and Uganda II) a genetically well-defined subspecies of the Mycobacterium tuberculosis complex?

Authors:  Christophe Sola; Nalin Rastogi; M Cristina Gutierrez; Véronique Vincent; Roland Brosch; Linda Parsons
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

2.  Rapid testing for nitrate reductase activity of Mycobacterium tuberculosis grown in an automated culture system.

Authors:  A Meyer; L Sedlacek; F-C Bange
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-24       Impact factor: 3.267

3.  Molecular fingerprinting of Mycobacterium bovis subsp. caprae isolates from central Europe.

Authors:  Wilfried Erler; Gerald Martin; Konrad Sachse; Ludmila Naumann; Dagmar Kahlau; Jörg Beer; Milan Bartos; György Nagy; Zeljko Cvetnic; Manca Zolnir-Dovc; Ivo Pavlik
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

4.  Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States.

Authors:  M M Hannan; E P Desmond; G P Morlock; G H Mazurek; J T Crawford
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

Review 5.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

6.  Mycobacterium bovis subsp. caprae caused one-third of human M. bovis-associated tuberculosis cases reported in Germany between 1999 and 2001.

Authors:  Tanja Kubica; Sabine Rüsch-Gerdes; Stefan Niemann
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda.

Authors:  S Niemann; S Rüsch-Gerdes; M L Joloba; C C Whalen; D Guwatudde; J J Ellner; K Eisenach; N Fumokong; J L Johnson; T Aisu; R D Mugerwa; A Okwera; S K Schwander
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Two cases of Mycobacterium microti derived tuberculosis in HIV-negative immunocompetent patients.

Authors:  S Niemann; E Richter; H Dalügge-Tamm; H Schlesinger; D Graupner; B Königstein; G Gurath; U Greinert; S Rüsch-Gerdes
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883

9.  Distinct genotypic profiles of the two major clades of Mycobacterium africanum.

Authors:  Sidra E Gonçalves Vasconcellos; Richard C Huard; Stefan Niemann; Kristin Kremer; Adalberto R Santos; Philip N Suffys; John L Ho
Journal:  BMC Infect Dis       Date:  2010-03-29       Impact factor: 3.090

10.  Spoligologos: a bioinformatic approach to displaying and analyzing Mycobacterium tuberculosis data.

Authors:  Jeffrey R Driscoll; Pablo J Bifani; Barun Mathema; Michael A McGarry; Genét M Zickas; Barry N Kreiswirth; Harry W Taber
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.